VEGF-related germinal polymorphisms may identify a subgroup of breast Cancer patients with favorable outcome under bevacizumab-based therapy: a message from COMET, a French Unicancer Multicentric Study
Nom du journal : Pharmaceuticals (Basel)
Année : 2020
Volume : 13
Page de départ : 414